Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the efficacy of memantine in children with attention deficit hyperactivity disorder
IRCT2016080829268N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine in attention deficit hyperactivity disorder (ADHD), sponsored by Arak University of Medical Sciences. Started Apr 2016; status: completed.
02
Drugs
memantine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT2016080829268N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016080829268N1.